Medically reviewed by Gagandeep Brar, MD Key Takeaways ITP does not increase the risk of getting or having severe ...

Immune thrombocytopenia (ITP) doesn’t have a cure and can be unpredictable. There are two main types of ITP, acute and chronic. The acute type usually lasts six months or less. It’s more common in ...

Administration of high-dose IVIg rapidly increases platelet numbers in individuals with the platelet autoimmune disease ITP. Although also of benefit in other autoimmune disorders, including ...

Following the FDA approval of rilzabrutinib (Wayrilz; Sanofi) for immune thrombocytopenia (ITP), a rare autoimmune disorder, David Kuter, MD, DPhil, highlights the most pressing a ...

Immune thrombocytopenia (ITP) occurs when the immune system attacks and destroys healthy platelets. A person who has ITP is more likely to bruise or bleed. Thrombocytopenia means a person does not ...